NuVasive (NUVA +3.8%) trades up after Brean Murray initiates the shares with a Buy and a $30...

|By:, SA News Editor

NuVasive (NUVA +3.8%) trades up after Brean Murray initiates the shares with a Buy and a $30 price target. The firm says that with as solid a pipeline as NUVA has, expectations for the medical-device company look conservative now that it has "successfully defended" its core U.S. spinal-products business.